These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17376636)

  • 21. Quantifying the exact allocation ratios in randomized clinical trials with biased coin randomization.
    Lin Y; Su Z
    Comput Methods Programs Biomed; 2012 Oct; 108(1):197-202. PubMed ID: 22607968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative efficiency of unequal cluster sizes for variance component estimation in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Methods Med Res; 2008 Aug; 17(4):439-58. PubMed ID: 17698940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of realistic sample size calculations and why the next randomized trial needs to be large and multicentered.
    Li TS; Lee A; Joynt GM
    Crit Care Med; 2007 Feb; 35(2):675-6. PubMed ID: 17251734
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases.
    van der Lee JH; Wesseling J; Tanck MW; Offringa M
    J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomization in substance abuse clinical trials.
    Hedden SL; Woolson RF; Malcolm RJ
    Subst Abuse Treat Prev Policy; 2006 Feb; 1():6. PubMed ID: 16722591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A SAS macro for constrained randomization of group-randomized designs.
    Chaudhary MA; Moulton LH
    Comput Methods Programs Biomed; 2006 Sep; 83(3):205-10. PubMed ID: 16870302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual allocation had an advantage over cluster randomization in statistical efficiency in some circumstances.
    Hewitt CE; Torgerson DJ; Miles JN
    J Clin Epidemiol; 2008 Oct; 61(10):1004-8. PubMed ID: 18411038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varying cluster sizes in trials with clusters in one treatment arm: sample size adjustments when testing treatment effects with linear mixed models.
    Candel MJ; Van Breukelen GJ
    Stat Med; 2009 Aug; 28(18):2307-24. PubMed ID: 19472169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.
    Willan A; Kowgier M
    Clin Trials; 2008; 5(4):289-300. PubMed ID: 18697843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R; Alemi F
    Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On sample size calculation for 2x2 fixed-effect ANOVA when variances are unknown and possibly unequal.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2009 May; 62(Pt 2):417-25. PubMed ID: 18559139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
    Scales CD; Norris RD; Preminger GM; Vieweg J; Peterson BL; Dahm P
    J Urol; 2008 Oct; 180(4):1463-7. PubMed ID: 18710745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining a proper sample size.
    Fogel J
    Fam Pract Manag; 2004 Oct; 11(9):14; author reply 14. PubMed ID: 15552243
    [No Abstract]   [Full Text] [Related]  

  • 38. Stratified experiments reexamined with emphasis on multicenter trials.
    Ganju J; Mehrotra DV
    Control Clin Trials; 2003 Apr; 24(2):167-81. PubMed ID: 12689738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing performance of a randomized versus a non-randomized study design.
    Raaijmakers M; Koffijberg H; Posthumus J; van Hout B; van Engeland H; Matthys W
    Contemp Clin Trials; 2008 Mar; 29(2):293-303. PubMed ID: 17707138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.